Campbell & Co Investment Adviser’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
197,926
+153,447
+345% +$1.19M 0.11% 302
2026
Q1
$283K Buy
+44,479
New +$310K 0.02% 894
2025
Q4
Sell
-55,820
Closed -$307K 1282
2025
Q3
$307K Sell
55,820
-44,666
-44% -$219K 0.02% 906
2025
Q2
$520K Buy
+100,486
New +$602K 0.03% 770

Other funds holding LFST

Campbell & Co Investment Adviser's LFST Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its Lifestance Health (LFST) stake by 345% in Q2 2026, buying an estimated $1.19M and bringing the position to 197,926 shares worth $2.12M. The position accounts for 0.11% of the portfolio, ranked #302.

Campbell & Co Investment Adviser first reported a position in LFST in Q2 2025 and has held it in 4 quarters since. 69 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Campbell & Co Investment Adviser held 197,926 shares of Lifestance Health worth $2.12M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 153,447 Lifestance Health shares in Q2 2026, an estimated $1.19M.
  • Lifestance Health made up 0.11% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #302 holding.
  • Campbell & Co Investment Adviser first reported a position in Lifestance Health in Q2 2025 and has held it in 4 quarters since.
  • 69 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.